Sol-Gel Announces Initiation of SGT-210 Phase 1 Proof of Concept Study in Palmoplantar Keratoderma (PPK)
Sol-Gel Technologies Ltd. - Ordinary Shares (SLGL)
Last sol-gel technologies ltd. - ordinary shares earnings: 11/13 07:05 am
Check Earnings Report
US:NASDAQ Investor Relations:
nasdaq.com/markets/ipos/company/solgel-technologies-ltd-1031585-84610
Company Research
Source: GlobeNewswire
NESS ZIONA, Israel, Jan. 02, 2020 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (NASDAQ: SLGL) today announced the initiation of a Phase 1 proof of concept clinical study of SGT-210, its novel, topical, epidermal growth factor receptor inhibitor in patients with punctate palmoplantar keratoderma type -1 (PPPK type 1), a genetic form of PPK. Top-line data is expected in the first half of 2021. “Patients with PPK suffer from the physical manifestations of the disease and the thickened skin can interfere with daily activities,” said Dr. Eli Sprecher MD, Ph.D., Chairman of the Division of Dermatology at the Tel Aviv Sourasky Medical Center. “I am delighted that The Tel Aviv Medical Center is running a clinical trial aimed at assessing the clinical efficacy of Sol-Gel’s novel product.” The Phase 1 proof of concept study SGT-84-01 is a single-center, single-blinded, vehicle-controlled study designed to evaluate the bioavailability, safety and tolerability of SGT-210 as well as inform
Show less
Read more
Impact Snapshot
Event Time:
SLGL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SLGL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SLGL alerts
High impacting Sol-Gel Technologies Ltd. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
SLGL
News
- Is SolGel Technologies (SLGL) a Great Value Stock Right Now? [Yahoo! Finance]Yahoo! Finance
- Sol-Gel announces 180-day extension period for Nasdaq compliance Nov. 20, 2024 9:26 AM ET By: Khushi Singh , SA News Editor [Seeking Alpha]Seeking Alpha
- Sol-Gel Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Requirement [Yahoo! Finance]Yahoo! Finance
- Sol-Gel Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid RequirementGlobeNewswire
SLGL
Earnings
- 11/15/24 - Beat
SLGL
Sec Filings
- 2/13/25 - Form SCHEDULE
- 11/20/24 - Form 6-K
- SLGL's page on the SEC website